Patent · US Active

Modified alginates for cell encapsulation and cell therapy

US10842753B2 · kind B2 · utility

1Cited by

10References

20Claims

0Family size

Assignees

Inventors

Arturo Jose Vegas · Belmont, US
Minglin Ma · Ithaca, US
Kaitlin M. Bratlie · Ames, US
Daniel Griffith Anderson · Framingham, US
Robert S. Langer · Newton, US

Key dates

Filing date	May 10, 2019
Grant date	Nov 24, 2020
Priority date	—
Expiry date	May 10, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/5161
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Covalently modified alginate polymers, possessing enhanced biocompatibility and tailored physiochemical properties, as well as methods of making and use thereof, are disclosed herein. The covalently modified alginates are useful as a matrix for the encapsulation and transplantation of cells. Also disclosed are high throughput methods for the characterizing the biocompatibility and physiochemical properties of modified alginate polymers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.